VistaGen Therapeutics Expands European Patent Protection for AV-101 for Treatment of Depression and Dyskinesia associated with Levodopa Therapy for Parkinson's Disease

Stock Information for VistaGen Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.